"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","25/36","481/2914",1.59510405613764e-12,7.48103802328551e-10,4.41591965014946e-10,"EP300/CDK1/SUMO1/UBE2I/MAPK1/BRCA1/ATF2/PPP2CA/PPP2R1B/YAP1/CSNK2A1/SMAD3/PCGF2/RB1/E2F1/SP1/SMAD2/NR0B2/STAT1/MEF2C/FOS/NOTCH1/RUNX2/SMAD4/CTNNB1",25
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","25/36","499/2914",3.78420437383197e-12,8.87395925663598e-10,5.23813552798847e-10,"EP300/CDK1/SUMO1/UBE2I/MAPK1/BRCA1/ATF2/PPP2CA/PPP2R1B/YAP1/CSNK2A1/SMAD3/PCGF2/RB1/E2F1/SP1/SMAD2/NR0B2/STAT1/MEF2C/FOS/NOTCH1/RUNX2/SMAD4/CTNNB1",25
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","5/36","11/2914",9.46134203742047e-08,1.47912313851673e-05,8.73099282751433e-06,"CDK1/PPP2CA/PPP2R1B/RB1/E2F1",5
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","6/36","30/2914",1.10433403703878e-06,0.000129483165842797,7.64315399318944e-05,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS",6
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","6/36","33/2914",2.00560325663239e-06,0.000188125585472118,0.000111047085577751,"CDK1/MAPK1/PPP2CA/PPP2R1B/RB1/PLK1",6
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","4/36","10/2914",3.9129023937883e-06,0.000305858537114452,0.000180542689397601,"PPP2CA/PPP2R1B/RB1/E2F1",4
"R-HSA-450294","R-HSA-450294","MAP kinase activation","7/36","60/2914",5.75269418639513e-06,0.000385430510488473,0.000227512567070965,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","7/36","62/2914",7.19708056747498e-06,0.000403913711594426,0.000238422861966859,"CDK1/MAPK1/YAP1/RB1/STAT1/RUNX2/SMAD4",7
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","5/36","24/2914",7.75100939093781e-06,0.000403913711594426,0.000238422861966859,"MAPK1/YAP1/RB1/RUNX2/SMAD4",5
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","7/36","64/2914",8.93165025535174e-06,0.000418894396975997,0.00024726568601658,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","4/36","14/2914",1.80042037142102e-05,0.000527748221372788,0.000311520103739296,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","4/36","14/2914",1.80042037142102e-05,0.000527748221372788,0.000311520103739296,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","4/36","14/2914",1.80042037142102e-05,0.000527748221372788,0.000311520103739296,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","4/36","14/2914",1.80042037142102e-05,0.000527748221372788,0.000311520103739296,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","4/36","14/2914",1.80042037142102e-05,0.000527748221372788,0.000311520103739296,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","4/36","14/2914",1.80042037142102e-05,0.000527748221372788,0.000311520103739296,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","12/36","249/2914",2.2701121263583e-05,0.000626283874860026,0.000369683894261445,"EP300/CDK1/SUMO1/UBE2I/MAPK1/BRCA1/PPP2CA/PPP2R1B/CSNK2A1/RB1/E2F1/PLK1",12
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","15/36","397/2914",2.88930570195068e-05,0.000683887781033138,0.000403686424445551,"EP300/MAPK1/CSNK2A1/SMAD3/PCGF2/RPS6KA4/E2F1/SMAD2/ROCK2/MEF2C/CEBPE/PAK1/NOTCH1/SMAD4/CTNNB1",15
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","4/36","16/2914",3.21620291931704e-05,0.000683887781033138,0.000403686424445551,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","7/36","78/2914",3.35556829919918e-05,0.000683887781033138,0.000403686424445551,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","7/36","78/2914",3.35556829919918e-05,0.000683887781033138,0.000403686424445551,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","7/36","78/2914",3.35556829919918e-05,0.000683887781033138,0.000403686424445551,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","6/36","53/2914",3.4781624488265e-05,0.000683887781033138,0.000403686424445551,"EP300/YAP1/SMAD3/NOTCH1/SMAD4/CTNNB1",6
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","8/36","108/2914",3.49963896477512e-05,0.000683887781033138,0.000403686424445551,"EP300/SOX17/PPP2CA/PPP2R1B/CSNK2A1/CTNNB1/SOX6/AMER1",8
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","7/36","83/2914",5.04479199788481e-05,0.000913679757731368,0.000539328417199753,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","4/36","18/2914",5.31284534640065e-05,0.000913679757731368,0.000539328417199753,"CDK1/PPP2CA/PPP2R1B/PLK1",4
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","7/36","84/2914",5.45480452376936e-05,0.000913679757731368,0.000539328417199753,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","7/36","84/2914",5.45480452376936e-05,0.000913679757731368,0.000539328417199753,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","7/36","86/2914",6.35723068792243e-05,0.000918222155455535,0.00054200971133387,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","7/36","86/2914",6.35723068792243e-05,0.000918222155455535,0.00054200971133387,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","7/36","86/2914",6.35723068792243e-05,0.000918222155455535,0.00054200971133387,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","4/36","19/2914",6.67047758069556e-05,0.000918222155455535,0.00054200971133387,"MAPK1/YAP1/RB1/RUNX2",4
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","7/36","87/2914",6.85240414519056e-05,0.000918222155455535,0.00054200971133387,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","7/36","87/2914",6.85240414519056e-05,0.000918222155455535,0.00054200971133387,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","7/36","87/2914",6.85240414519056e-05,0.000918222155455535,0.00054200971133387,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","7/36","90/2914",8.53129862588479e-05,0.00108139974474053,0.000638330451950981,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","7/36","90/2914",8.53129862588479e-05,0.00108139974474053,0.000638330451950981,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","4/36","21/2914",0.000101198318113426,0.00124900029461045,0.000737261985147676,"MAPK1/PPP2CA/PPP2R1B/MEF2C",4
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","6/36","68/2914",0.000145034774298108,0.00172483717411969,0.00101813977509478,"EP300/CDK1/PPP2CA/PPP2R1B/E2F1/PLK1",6
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","4/36","23/2914",0.000147107648112554,0.00172483717411969,0.00101813977509478,"MAPK1/RB1/E2F1/SP1",4
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","4/36","24/2914",0.000174978975856877,0.00195393189706846,0.00115337019173831,"MAPK1/PPP2CA/PPP2R1B/MEF2C",4
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/36","24/2914",0.000174978975856877,0.00195393189706846,0.00115337019173831,"SMAD3/SP1/SMAD2/SMAD4",4
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/36","10/2914",0.000195918290771183,0.00213687624120197,0.00126135888550357,"MAPK1/ATF2/FOS",3
"R-HSA-68886","R-HSA-68886","M Phase","7/36","105/2914",0.000227456599961823,0.00242448057686579,0.00143112645430525,"CDK1/MAPK1/PPP2CA/PPP2R1B/CSNK2A1/RB1/PLK1",7
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","11/36","268/2914",0.000241024379176503,0.00251200964075066,0.00148279325668819,"EP300/MAPK1/PPP2CA/PPP2R1B/SMAD3/SMAD2/STAT1/NOTCH1/SMAD4/CTNNB1/AMER1",11
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","7/36","110/2914",0.000304165811854363,0.00310116882086297,0.00183056312397477,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","3/36","12/2914",0.000353115543565659,0.00345023312358946,0.00203660938503878,"SMAD3/SMAD2/SMAD4",3
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","3/36","12/2914",0.000353115543565659,0.00345023312358946,0.00203660938503878,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","9/36","191/2914",0.000369469391892108,0.00353634989382446,0.00208744253636143,"EP300/CDK1/MAPK1/PPP2CA/PPP2R1B/CSNK2A1/RB1/E2F1/PLK1",9
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","9/36","194/2914",0.000415349605884062,0.00374507154557097,0.00221064710242434,"EP300/CDK1/BRCA1/ATF2/PPP2CA/PPP2R1B/CSNK2A1/E2F1/FOS",9
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","4/36","30/2914",0.000428026596102411,0.00374507154557097,0.00221064710242434,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","3/36","13/2914",0.000455157949035278,0.00374507154557097,0.00221064710242434,"PPP2CA/PPP2R1B/AMER1",3
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","3/36","13/2914",0.000455157949035278,0.00374507154557097,0.00221064710242434,"PPP2CA/PPP2R1B/AMER1",3
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","3/36","13/2914",0.000455157949035278,0.00374507154557097,0.00221064710242434,"PPP2CA/PPP2R1B/AMER1",3
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","3/36","13/2914",0.000455157949035278,0.00374507154557097,0.00221064710242434,"PPP2CA/PPP2R1B/AMER1",3
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","3/36","13/2914",0.000455157949035278,0.00374507154557097,0.00221064710242434,"PPP2CA/PPP2R1B/AMER1",3
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","3/36","13/2914",0.000455157949035278,0.00374507154557097,0.00221064710242434,"PPP2CA/PPP2R1B/AMER1",3
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","4/36","31/2914",0.000487125634583618,0.00393899866585719,0.00232511872768587,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","5/36","56/2914",0.000523473112425279,0.00416116762249925,0.00245626099139783,"CDK1/PPP2CA/PPP2R1B/CSNK2A1/PLK1",5
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","3/36","14/2914",0.000574381697759206,0.0044897502708178,0.00265021730720476,"SMAD3/SMAD2/SMAD4",3
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","7/36","124/2914",0.000635119403549163,0.00488313115187799,0.00288242283232838,"EP300/CDK1/BRCA1/SMAD3/SMAD2/SMAD4/TRAF6",7
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","4/36","34/2914",0.000699239684723044,0.0052894098731469,0.00312224171616572,"CDK1/PPP2CA/PPP2R1B/PLK1",4
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","3/36","15/2914",0.00071189327322705,0.0052923156644326,0.00312395695151111,"SMAD3/SMAD2/SMAD4",3
"R-HSA-69206","R-HSA-69206","G1/S Transition","5/36","60/2914",0.000722192329474811,0.0052923156644326,0.00312395695151111,"CDK1/PPP2CA/PPP2R1B/RB1/E2F1",5
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","7/36","127/2914",0.000734017550153785,0.00529621893880193,0.00312626098284122,"MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/FOS/TRAF6",7
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","7/36","130/2914",0.000844834850292695,0.00600344764829203,0.00354372512961689,"MAPK1/PPP2CA/PPP2R1B/ROCK2/PAK1/PLK1/CTNNB1",7
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","4/36","36/2914",0.00087263682553741,0.00610845777876187,0.00360571068525277,"SMAD3/SP1/SMAD2/SMAD4",4
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","6/36","95/2914",0.000904492534104477,0.00618965551633513,0.00365364022173974,"EP300/CDK1/BRCA1/PPP2CA/PPP2R1B/CSNK2A1",6
"R-HSA-195721","R-HSA-195721","Signaling by WNT","8/36","172/2914",0.000910631621806235,0.00618965551633513,0.00365364022173974,"EP300/SOX17/PPP2CA/PPP2R1B/CSNK2A1/CTNNB1/SOX6/AMER1",8
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","4/36","37/2914",0.000969831540028592,0.00640635200385084,0.00378155218721304,"PPP2CA/PPP2R1B/CTNNB1/AMER1",4
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","4/36","37/2914",0.000969831540028592,0.00640635200385084,0.00378155218721304,"EP300/SUMO1/UBE2I/PCGF2",4
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","3/36","17/2914",0.00104598273389785,0.00672008085202868,0.00396674057700268,"SUMO1/UBE2I/PCGF2",3
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/36","17/2914",0.00104598273389785,0.00672008085202868,0.00396674057700268,"EP300/SMAD3/NOTCH1",3
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","4/36","38/2914",0.00107442580305702,0.00680953650856406,0.00401954461172113,"SUMO1/UBE2I/BRCA1/PCGF2",4
"R-HSA-69275","R-HSA-69275","G2/M Transition","5/36","66/2914",0.00112010981019945,0.00700442001311389,0.00413458077308709,"EP300/CDK1/PPP2CA/PPP2R1B/PLK1",5
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","3/36","18/2914",0.00124455358998463,0.0075804627753609,0.00447460825927487,"BRCA1/PCGF2/E2F1",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/36","18/2914",0.00124455358998463,0.0075804627753609,0.00447460825927487,"EP300/STAT1/NOTCH1",3
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","4/36","40/2914",0.00130702165542057,0.00775940704293986,0.00458023578115404,"PPP2CA/PPP2R1B/RB1/E2F1",4
"R-HSA-69236","R-HSA-69236","G1 Phase","4/36","40/2914",0.00130702165542057,0.00775940704293986,0.00458023578115404,"PPP2CA/PPP2R1B/RB1/E2F1",4
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","3/36","19/2914",0.00146540024264294,0.00859090892249423,0.00507105610283017,"SMAD3/SMAD2/SMAD4",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/36","20/2914",0.00170941526404401,0.00977702144922734,0.00577119659106002,"SMAD3/SMAD2/SMAD4",3
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/36","20/2914",0.00170941526404401,0.00977702144922734,0.00577119659106002,"MAPK1/CSNK2A1/PAK1",3
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","5/36","77/2914",0.00224469301902266,0.0126838677821883,0.00748705471151504,"CDK1/PPP2CA/PPP2R1B/RB1/E2F1",5
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","6/36","114/2914",0.00234095867963724,0.0130703526279746,0.00771518963339091,"CDK1/SUMO1/BRCA1/PPP2CA/PPP2R1B/PLK1",6
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","3/36","23/2914",0.00258880487565312,0.014118017286992,0.0083336068824574,"EP300/E2F1/NOTCH1",3
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","3/36","23/2914",0.00258880487565312,0.014118017286992,0.0083336068824574,"SUMO1/UBE2I/PCGF2",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","4/36","49/2914",0.00279946706745288,0.0149198869844932,0.00880693587009699,"EP300/ATF2/SP1/FOS",4
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","4/36","49/2914",0.00279946706745288,0.0149198869844932,0.00880693587009699,"EP300/SMAD3/SMAD2/SMAD4",4
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","3/36","25/2914",0.00330552231825922,0.0174189883962199,0.0102821096357442,"EP300/SUMO1/UBE2I",3
"R-HSA-373760","R-HSA-373760","L1CAM interactions","4/36","53/2914",0.00373534194389283,0.0194652819076193,0.0114899991958341,"MAPK1/CSNK2A1/RPS6KA4/PAK1",4
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","3/36","27/2914",0.00413308759045488,0.0213012975815752,0.0125737656019622,"EP300/E2F1/CEBPE",3
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","3/36","28/2914",0.00459000074922443,0.0233990255585463,0.0138120159845083,"SMAD3/SMAD2/SMAD4",3
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","3/36","29/2914",0.00507643460464245,0.0245448229853331,0.0144883592080409,"PPP2CA/PPP2R1B/PLK1",3
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","3/36","29/2914",0.00507643460464245,0.0245448229853331,0.0144883592080409,"PPP2CA/PPP2R1B/PLK1",3
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","3/36","29/2914",0.00507643460464245,0.0245448229853331,0.0144883592080409,"EP300/E2F1/NOTCH1",3
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","3/36","29/2914",0.00507643460464245,0.0245448229853331,0.0144883592080409,"CDK1/PPP2CA/PPP2R1B",3
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/36","29/2914",0.00507643460464245,0.0245448229853331,0.0144883592080409,"CDK1/PPP2CA/PPP2R1B",3
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","3/36","30/2914",0.00559292438336913,0.0264957730888901,0.0156399693017127,"MAPK1/PAK1/FOS",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/36","30/2914",0.00559292438336913,0.0264957730888901,0.0156399693017127,"EP300/CDK1/E2F1",3
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","11/36","393/2914",0.00593367882259241,0.0278289536779584,0.016426921372019,"EP300/CDK1/SUMO1/UBE2I/BRCA1/SMAD3/PCGF2/PEX14/SMAD2/SMAD4/TRAF6",11
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","3/36","31/2914",0.00613997424931043,0.0283016860453697,0.0167059666253669,"SOX17/CTNNB1/SOX6",3
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","2/36","10/2914",0.00627585362200096,0.0283016860453697,0.0167059666253669,"UBE2I/BRCA1",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/36","10/2914",0.00627585362200096,0.0283016860453697,0.0167059666253669,"CDK1/E2F1",2
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","2/36","10/2914",0.00627585362200096,0.0283016860453697,0.0167059666253669,"SUMO1/UBE2I",2
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","5/36","99/2914",0.00667703317629004,0.0298240815207622,0.0176046087755818,"MAPK1/RB1/E2F1/SP1/FOS",5
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","4/36","63/2914",0.00695959782964809,0.0307929375670279,0.0181765067447612,"SMAD3/SP1/SMAD2/SMAD4",4
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/36","11/2914",0.00761113173652724,0.0330520443002896,0.0195100160497726,"SMAD2/SMAD4",2
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","2/36","11/2914",0.00761113173652724,0.0330520443002896,0.0195100160497726,"ROCK2/PAK1",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","3/36","34/2914",0.0079690764744257,0.0336711429414924,0.0198754586322803,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","3/36","34/2914",0.0079690764744257,0.0336711429414924,0.0198754586322803,"SUMO1/UBE2I/BRCA1",3
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","3/36","34/2914",0.0079690764744257,0.0336711429414924,0.0198754586322803,"BRCA1/ATF2/FOS",3
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","5/36","104/2914",0.00821057915355388,0.0343818002055069,0.0202949465919612,"EP300/SMAD3/E2F1/STAT1/NOTCH1",5
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","3/36","35/2914",0.00864281427847138,0.0358715035097617,0.0211742911526593,"SUMO1/UBE2I/BRCA1",3
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","2/36","12/2914",0.00906273497511956,0.0369601974202702,0.0218169272169926,"YAP1/RUNX2",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/36","12/2914",0.00906273497511956,0.0369601974202702,0.0218169272169926,"EP300/NOTCH1",2
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","5/36","107/2914",0.00924078026756861,0.0373614305645662,0.0220537677892064,"EP300/SUMO1/UBE2I/BRCA1/PCGF2",5
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","5/36","108/2914",0.00960331831399457,0.0384953528996876,0.0227231013637478,"EP300/MAPK1/ATF2/SP1/FOS",5
"R-HSA-2990846","R-HSA-2990846","SUMOylation","5/36","109/2914",0.00997564085262695,0.039429414539064,0.0232744608321711,"EP300/SUMO1/UBE2I/BRCA1/PCGF2",5
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","4/36","70/2914",0.0100748395240313,0.039429414539064,0.0232744608321711,"MAPK1/PPP2CA/PPP2R1B/MEF2C",4
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/36","37/2914",0.0100885495622339,0.039429414539064,0.0232744608321711,"EP300/STAT1/NOTCH1",3
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","2/36","13/2914",0.0106277489798622,0.0405236932646777,0.0239203935105156,"SUMO1/UBE2I",2
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","2/36","13/2914",0.0106277489798622,0.0405236932646777,0.0239203935105156,"EP300/BRCA1",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/36","13/2914",0.0106277489798622,0.0405236932646777,0.0239203935105156,"EP300/NOTCH1",2
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/36","14/2914",0.012303310193546,0.0461620198461845,0.0272485943654955,"MAPK1/PPP2CA",2
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","2/36","14/2914",0.012303310193546,0.0461620198461845,0.0272485943654955,"SUMO1/STAT1",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","3/36","40/2914",0.0125074245395627,0.0465554135639277,0.0274808074678779,"EP300/SMAD3/NOTCH1",3
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","2/36","15/2914",0.0140866051043643,0.0508201368765142,0.0299981954854073,"CDK1/PLK1",2
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","2/36","15/2914",0.0140866051043643,0.0508201368765142,0.0299981954854073,"PPP2CA/PPP2R1B",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/36","15/2914",0.0140866051043643,0.0508201368765142,0.0299981954854073,"EP300/CDK1",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/36","15/2914",0.0140866051043643,0.0508201368765142,0.0299981954854073,"CDK1/E2F1",2
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","3/36","42/2914",0.014289873222328,0.0511599277959682,0.0301987678382665,"PPP2CA/PPP2R1B/PLK1",3
"R-HSA-1643685","R-HSA-1643685","Disease","11/36","443/2914",0.0145210981474345,0.051593901751112,0.0304549347111266,"EP300/MAPK1/PPP2CA/PPP2R1B/SMAD3/SMAD2/STAT1/NOTCH1/SMAD4/CTNNB1/AMER1",11
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","4/36","80/2914",0.0159210647625468,0.0550898073224993,0.0325185037051225,"CDK1/ATF2/MEF2C/PLK1",4
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","4/36","80/2914",0.0159210647625468,0.0550898073224993,0.0325185037051225,"SMAD3/SMAD2/SMAD4/TRAF6",4
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/36","16/2914",0.0159748695007674,0.0550898073224993,0.0325185037051225,"SUMO1/UBE2I",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/36","16/2914",0.0159748695007674,0.0550898073224993,0.0325185037051225,"CDK1/PLK1",2
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","3/36","44/2914",0.016210135284576,0.0554930908647163,0.0327565545896541,"MAPK1/E2F1/FOS",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","9/36","332/2914",0.0166775472272583,0.0566794902143779,0.0334568643842024,"MAPK1/ATF2/PPP2CA/PPP2R1B/SMAD3/STAT1/MEF2C/FOS/TRAF6",9
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","6/36","172/2914",0.0171697644493804,0.0579325145810028,0.0341965017053164,"MAPK1/ATF2/PPP2CA/PPP2R1B/CSNK2A1/TRAF6",6
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","2/36","17/2914",0.01796538773635,0.0601840489167725,0.0355255411628575,"SUMO1/UBE2I",2
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","3/36","46/2914",0.018269460033706,0.0607686294738165,0.0358706083528532,"CDK1/SUMO1/BRCA1",3
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","7/36","228/2914",0.0192208644036684,0.0630269886148701,0.0372036763678842,"MAPK1/PPP2CA/PPP2R1B/ROCK2/PAK1/PLK1/CTNNB1",7
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","3/36","47/2914",0.01935157006512,0.0630269886148701,0.0372036763678842,"PPP2CA/PPP2R1B/PLK1",3
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","3/36","47/2914",0.01935157006512,0.0630269886148701,0.0372036763678842,"SUMO1/STAT1/CIITA",3
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/36","18/2914",0.0200554920046457,0.0647156456321054,0.0382004596593956,"EP300/CSNK2A1",2
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","4/36","86/2914",0.0202840083324509,0.0647156456321054,0.0382004596593956,"EP300/YAP1/CSNK2A1/RUNX2",4
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","4/36","86/2914",0.0202840083324509,0.0647156456321054,0.0382004596593956,"SMAD3/SP1/SMAD2/SMAD4",4
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","3/36","48/2914",0.0204687649026527,0.0648638563469198,0.0382879457282907,"SUMO1/UBE2I/BRCA1",3
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","4/36","87/2914",0.0210765207146098,0.0663415316453156,0.0391601903775513,"MAPK1/PAK1/FOS/TRAF6",4
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","9/36","347/2914",0.0218020558028198,0.0677387103994646,0.0399849193918959,"MAPK1/PPP2CA/PPP2R1B/YAP1/ROCK2/STAT1/MEF2C/PAK1/CTNNB1",9
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","2/36","19/2914",0.0222425616237048,0.0677387103994646,0.0399849193918959,"CDK1/E2F1",2
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","2/36","19/2914",0.0222425616237048,0.0677387103994646,0.0399849193918959,"CDK1/PLK1",2
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","2/36","19/2914",0.0222425616237048,0.0677387103994646,0.0399849193918959,"PPP2CA/PPP2R1B",2
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","2/36","19/2914",0.0222425616237048,0.0677387103994646,0.0399849193918959,"EP300/PAK1",2
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","4/36","89/2914",0.0227186996706613,0.0687423880357429,0.0405773719075309,"MAPK1/PPP2CA/PPP2R1B/MEF2C",4
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","5/36","136/2914",0.0241603994211261,0.0723381539177769,0.0426998866128949,"EP300/MAPK1/ATF2/SP1/FOS",5
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","2/36","20/2914",0.0245240223303338,0.0723381539177769,0.0426998866128949,"MAPK1/RPS6KA4",2
"R-HSA-70171","R-HSA-70171","Glycolysis","2/36","20/2914",0.0245240223303338,0.0723381539177769,0.0426998866128949,"PPP2CA/PPP2R1B",2
"R-HSA-70326","R-HSA-70326","Glucose metabolism","2/36","20/2914",0.0245240223303338,0.0723381539177769,0.0426998866128949,"PPP2CA/PPP2R1B",2
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","6/36","187/2914",0.0249569232002236,0.0731549811306555,0.0431820447477554,"EP300/MAPK1/RB1/E2F1/SP1/FOS",6
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/36","52/2914",0.0252894359353808,0.0733218085858803,0.0432805199373505,"EP300/ATF2/MEF2C",3
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","4/36","92/2914",0.0253265095755066,0.0733218085858803,0.0432805199373505,"MAPK1/PPP2CA/PPP2R1B/TRAF6",4
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","6/36","189/2914",0.0261505220062355,0.0752429130118063,0.0444145126744587,"EP300/MAPK1/RB1/E2F1/SP1/FOS",6
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","3/36","53/2914",0.0265826815748701,0.0760199857232565,0.0448732044556536,"PPP2CA/PPP2R1B/PAK1",3
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","2/36","21/2914",0.0268973455838743,0.0764536671444669,0.0451291986510937,"SUMO1/UBE2I",2
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","3/36","55/2914",0.0292747768964434,0.0805255114353229,0.047532733716732,"EP300/SUMO1/UBE2I",3
"R-HSA-1500620","R-HSA-1500620","Meiosis","2/36","22/2914",0.0293600478794034,0.0805255114353229,0.047532733716732,"UBE2I/BRCA1",2
"R-HSA-180024","R-HSA-180024","DARPP-32 events","2/36","22/2914",0.0293600478794034,0.0805255114353229,0.047532733716732,"PPP2CA/PPP2R1B",2
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/36","22/2914",0.0293600478794034,0.0805255114353229,0.047532733716732,"EP300/CTNNB1",2
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/36","22/2914",0.0293600478794034,0.0805255114353229,0.047532733716732,"SMAD3/SMAD2",2
"R-HSA-525793","R-HSA-525793","Myogenesis","2/36","22/2914",0.0293600478794034,0.0805255114353229,0.047532733716732,"MEF2C/CTNNB1",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","10/36","428/2914",0.0300141840867364,0.0818410019574382,0.0483092436646981,"EP300/MAPK1/ATF2/PPP2CA/PPP2R1B/MEF2C/PAK1/FOS/TRAF6/CTNNB1",10
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","3/36","56/2914",0.0306735371308057,0.0831554272505656,0.0490851248275138,"PPP2CA/PPP2R1B/PLK1",3
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","2/36","23/2914",0.0319096900702368,0.0860094519709257,0.0507698033180416,"CDK1/MAPK1",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","4/36","99/2914",0.0320990079396477,0.0860253412782559,0.0507791824849765,"MAPK1/PPP2CA/PPP2R1B/TRAF6",4
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","6/36","201/2914",0.0341299254654894,0.089904015245715,0.0530686926486883,"MAPK1/ATF2/PPP2CA/PPP2R1B/CSNK2A1/TRAF6",6
"R-HSA-1474165","R-HSA-1474165","Reproduction","2/36","24/2914",0.0345438766996172,0.089904015245715,0.0530686926486883,"UBE2I/BRCA1",2
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","2/36","24/2914",0.0345438766996172,0.089904015245715,0.0530686926486883,"EP300/NOTCH1",2
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","2/36","24/2914",0.0345438766996172,0.089904015245715,0.0530686926486883,"MAPK1/FOS",2
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","2/36","24/2914",0.0345438766996172,0.089904015245715,0.0530686926486883,"MAPK1/STAT1",2
"R-HSA-111885","R-HSA-111885","Opioid Signalling","3/36","59/2914",0.0350798183154922,0.089904015245715,0.0530686926486883,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","3/36","59/2914",0.0350798183154922,0.089904015245715,0.0530686926486883,"SUMO1/UBE2I/BRCA1",3
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","3/36","59/2914",0.0350798183154922,0.089904015245715,0.0530686926486883,"MAPK1/ATF2/CSNK2A1",3
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","3/36","60/2914",0.036618260162636,0.0933367609580233,0.0550949795353162,"PPP2CA/PPP2R1B/PLK1",3
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/36","25/2914",0.0372602553414744,0.0934495174072273,0.0551615376009444,"CDK1/PLK1",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/36","25/2914",0.0372602553414744,0.0934495174072273,0.0551615376009444,"CDK1/PLK1",2
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","2/36","25/2914",0.0372602553414744,0.0934495174072273,0.0551615376009444,"PAK1/CTNNB1",2
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","3/36","61/2914",0.0381913497588927,0.0952752289197907,0.0562392216494332,"PPP2CA/PPP2R1B/PLK1",3
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","3/36","62/2914",0.0397989520588687,0.0978463853157108,0.0577569281517943,"CDK1/SUMO1/BRCA1",3
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/36","26/2914",0.0400565159501417,0.0978463853157108,0.0577569281517943,"CDK1/PLK1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/36","26/2914",0.0400565159501417,0.0978463853157108,0.0577569281517943,"CDK1/PLK1",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/36","26/2914",0.0400565159501417,0.0978463853157108,0.0577569281517943,"STAT1/RUNX2",2
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","3/36","63/2914",0.0414409197703297,0.10067176506336,0.0594246980398689,"SUMO1/UBE2I/BRCA1",3
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/36","27/2914",0.0429303902189167,0.10067176506336,0.0594246980398689,"CDK1/PLK1",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/36","27/2914",0.0429303902189167,0.10067176506336,0.0594246980398689,"CDK1/PLK1",2
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","2/36","27/2914",0.0429303902189167,0.10067176506336,0.0594246980398689,"EP300/PCGF2",2
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","2/36","27/2914",0.0429303902189167,0.10067176506336,0.0594246980398689,"EP300/PCGF2",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/36","27/2914",0.0429303902189167,0.10067176506336,0.0594246980398689,"MAPK1/PPP2CA",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/36","27/2914",0.0429303902189167,0.10067176506336,0.0594246980398689,"CDK1/TRAF6",2
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","2/36","27/2914",0.0429303902189167,0.10067176506336,0.0594246980398689,"SUMO1/BRCA1",2
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","2/36","28/2914",0.0458796509473545,0.104963689240533,0.0619581422292901,"SUMO1/UBE2I",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/36","28/2914",0.0458796509473545,0.104963689240533,0.0619581422292901,"CDK1/PLK1",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/36","28/2914",0.0458796509473545,0.104963689240533,0.0619581422292901,"MAPK1/PPP2CA",2
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","2/36","28/2914",0.0458796509473545,0.104963689240533,0.0619581422292901,"UBE2I/SP1",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/36","28/2914",0.0458796509473545,0.104963689240533,0.0619581422292901,"EP300/TRAF6",2
"R-HSA-5673000","R-HSA-5673000","RAF activation","2/36","29/2914",0.0489021114171851,0.111335389585727,0.0657192401774128,"PPP2CA/PPP2R1B",2
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","2/36","30/2914",0.0519956247767434,0.116679177130587,0.0688735800366835,"CDK1/PLK1",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/36","30/2914",0.0519956247767434,0.116679177130587,0.0688735800366835,"MAPK1/PPP2CA",2
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","2/36","30/2914",0.0519956247767434,0.116679177130587,0.0688735800366835,"SUMO1/UBE2I",2
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","4/36","119/2914",0.0568964424051351,0.127068721371468,0.0750063376067695,"EP300/UBE2I/CSNK2A1/SP1",4
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","3/36","72/2914",0.0577352219654191,0.127961211477618,0.075533158160955,"EP300/PAK1/TRAF6",3
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","2/36","32/2914",0.0583874184567382,0.127961211477618,0.075533158160955,"ATF2/MEF2C",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/36","32/2914",0.0583874184567382,0.127961211477618,0.075533158160955,"MAPK1/PPP2CA",2
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","2/36","32/2914",0.0583874184567382,0.127961211477618,0.075533158160955,"MAPK1/ATF2",2
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/36","34/2914",0.0650386316406484,0.13928364492906,0.0822165831362199,"CDK1/PLK1",2
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","2/36","34/2914",0.0650386316406484,0.13928364492906,0.0822165831362199,"EP300/CTNNB1",2
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","2/36","34/2914",0.0650386316406484,0.13928364492906,0.0822165831362199,"EP300/ATF2",2
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","2/36","34/2914",0.0650386316406484,0.13928364492906,0.0822165831362199,"ROCK2/PAK1",2
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","2/36","34/2914",0.0650386316406484,0.13928364492906,0.0822165831362199,"CDK1/PAK1",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/36","37/2914",0.0754674589449694,0.160154924186383,0.0945365168017478,"CDK1/PLK1",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/36","37/2914",0.0754674589449694,0.160154924186383,0.0945365168017478,"MAPK1/PPP2CA",2
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","3/36","81/2914",0.0766418188270044,0.1619144731075,0.0955751462849794,"SUMO1/UBE2I/BRCA1",3
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/36","38/2914",0.0790566961784905,0.164789291145387,0.0972720986897918,"ATF2/MEF2C",2
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","2/36","38/2914",0.0790566961784905,0.164789291145387,0.0972720986897918,"ROCK2/PAK1",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/36","38/2914",0.0790566961784905,0.164789291145387,0.0972720986897918,"MAPK1/PPP2CA",2
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","2/36","39/2914",0.0826993611436384,0.171619470691887,0.101303828508509,"RB1/E2F1",2
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","3/36","85/2914",0.0858307582936412,0.175405337301953,0.103538556189909,"ROCK2/PAK1/CTNNB1",3
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/36","40/2914",0.0863936735964845,0.175405337301953,0.103538556189909,"CDK1/PLK1",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/36","40/2914",0.0863936735964845,0.175405337301953,0.103538556189909,"EP300/NOTCH1",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/36","40/2914",0.0863936735964845,0.175405337301953,0.103538556189909,"CDK1/PLK1",2
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","2/36","40/2914",0.0863936735964845,0.175405337301953,0.103538556189909,"RB1/E2F1",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/36","41/2914",0.0901378869205689,0.182218400714426,0.107560182668374,"MAPK1/PPP2CA",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","2/36","42/2914",0.0939302876054808,0.188261986696455,0.111127600720834,"PPP2CA/PPP2R1B",2
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/36","42/2914",0.0939302876054808,0.188261986696455,0.111127600720834,"CDK1/PLK1",2
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","2/36","43/2914",0.097769194732653,0.195122350338784,0.115177147658176,"MAPK1/PAK1",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","5/36","202/2914",0.0996213850356331,0.197976396532678,0.116861838824137,"CDK1/MAPK1/PPP2CA/PPP2R1B/PAK1",5
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","2/36","44/2914",0.101652959468276,0.20116134173258,0.118741853609401,"PPP2CA/PPP2R1B",2
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","3/36","92/2914",0.102993020828802,0.20295683516264,0.119801700477554,"ROCK2/PAK1/CTNNB1",3
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","2/36","45/2914",0.105579964563243,0.207184114561344,0.122296986038903,"MAPK1/FOS",2
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","2/36","46/2914",0.10954862386004,0.214076269126496,0.126365298575397,"SUMO1/UBE2I",2
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/36","47/2914",0.113557381806481,0.217872435659319,0.128606106112447,"EP300/SP1",2
"R-HSA-913531","R-HSA-913531","Interferon Signaling","3/36","97/2914",0.116038864417959,0.217872435659319,0.128606106112447,"SUMO1/STAT1/CIITA",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"CDK1",1
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"MAPK1",1
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"TRAF6",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"EP300",1
"R-HSA-74749","R-HSA-74749","Signal attenuation","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"MAPK1",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"CSNK2A1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"STAT1",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"STAT1",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"EP300",1
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","1/36","10/2914",0.11706578632441,0.217872435659319,0.128606106112447,"MAPK1",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/36","48/2914",0.117604712976213,0.218010317730608,0.128687495372349,"EP300/SP1",2
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","2/36","49/2914",0.121689121595897,0.223270342280033,0.131792391470427,"MAPK1/E2F1",2
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","2/36","49/2914",0.121689121595897,0.223270342280033,0.131792391470427,"EP300/MAPK1",2
"R-HSA-73894","R-HSA-73894","DNA Repair","4/36","157/2914",0.125690476135778,0.223270342280033,0.131792391470427,"EP300/SUMO1/UBE2I/BRCA1",4
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/36","50/2914",0.125809141078982,0.223270342280033,0.131792391470427,"MAPK1/PPP2CA",2
"R-HSA-109581","R-HSA-109581","Apoptosis","3/36","101/2914",0.126912842869602,0.223270342280033,0.131792391470427,"MAPK1/E2F1/CTNNB1",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"STAT1",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"E2F1",1
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"TRAF6",1
"R-HSA-209543","R-HSA-209543","p75NTR recruits signalling complexes","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"TRAF6",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"EP300",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"EP300",1
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"ROCK2",1
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"E2F1",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"CDK1",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/36","11/2914",0.128011251783198,0.223270342280033,0.131792391470427,"STAT1",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/36","51/2914",0.129963333565989,0.223270342280033,0.131792391470427,"EP300/NOTCH1",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/36","51/2914",0.129963333565989,0.223270342280033,0.131792391470427,"EP300/NOTCH1",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/36","51/2914",0.129963333565989,0.223270342280033,0.131792391470427,"EP300/NOTCH1",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/36","51/2914",0.129963333565989,0.223270342280033,0.131792391470427,"EP300/NOTCH1",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/36","51/2914",0.129963333565989,0.223270342280033,0.131792391470427,"EP300/NOTCH1",2
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","3/36","103/2914",0.132487366838352,0.225289997588081,0.132984556987241,"MAPK1/E2F1/CTNNB1",3
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"MAPK1",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"CSNK2A1",1
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"MAPK1",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"STAT1",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"NOTCH1",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"CDK1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"CTNNB1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"PAK1",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"PAK1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"CTNNB1",1
"R-HSA-937039","R-HSA-937039","IRAK1 recruits IKK complex","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"TRAF6",1
"R-HSA-975110","R-HSA-975110","TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"TRAF6",1
"R-HSA-975144","R-HSA-975144","IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"TRAF6",1
"R-HSA-975163","R-HSA-975163","IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation","1/36","12/2914",0.138824753311206,0.225289997588081,0.132984556987241,"TRAF6",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","6/36","289/2914",0.140052135432132,0.226498108681621,0.133697682826319,"EP300/UBE2I/PPP2CA/PPP2R1B/CSNK2A1/SP1",6
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/36","55/2914",0.146894056603553,0.229898936247778,0.135705129016195,"PPP2CA/PPP2R1B",2
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/36","55/2914",0.146894056603553,0.229898936247778,0.135705129016195,"MAPK1/PPP2CA",2
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"EP300",1
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"MAPK1",1
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"TRAF6",1
"R-HSA-205043","R-HSA-205043","NRIF signals cell death from the nucleus","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"TRAF6",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"NOTCH1",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"PAK1",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"CTNNB1",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"EP300",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"SP1",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"PAK1",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"BRCA1",1
"R-HSA-937072","R-HSA-937072","TRAF6-mediated induction of TAK1 complex within TLR4 complex","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"TRAF6",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/36","13/2914",0.149507837005484,0.229898936247778,0.135705129016195,"EP300",1
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","2/36","56/2914",0.151198520287729,0.231738908545571,0.136791230944866,"BRCA1/CSNK2A1",2
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","1/36","14/2914",0.160062031375634,0.238314580048166,0.140672729329295,"SP1",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/36","14/2914",0.160062031375634,0.238314580048166,0.140672729329295,"CTNNB1",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/36","14/2914",0.160062031375634,0.238314580048166,0.140672729329295,"PAK1",1
"R-HSA-5693554","R-HSA-5693554","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)","1/36","14/2914",0.160062031375634,0.238314580048166,0.140672729329295,"BRCA1",1
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","1/36","14/2914",0.160062031375634,0.238314580048166,0.140672729329295,"EP300",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/36","14/2914",0.160062031375634,0.238314580048166,0.140672729329295,"E2F1",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/36","14/2914",0.160062031375634,0.238314580048166,0.140672729329295,"EP300",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/36","14/2914",0.160062031375634,0.238314580048166,0.140672729329295,"PPP2CA",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/36","14/2914",0.160062031375634,0.238314580048166,0.140672729329295,"PPP2CA",1
"R-HSA-202403","R-HSA-202403","TCR signaling","2/36","59/2914",0.164263685185946,0.243796418836104,0.143908558307474,"PAK1/TRAF6",2
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/36","15/2914",0.170488847537867,0.24755191794198,0.146125360607655,"YAP1",1
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","1/36","15/2914",0.170488847537867,0.24755191794198,0.146125360607655,"ROCK2",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/36","15/2914",0.170488847537867,0.24755191794198,0.146125360607655,"EP300",1
"R-HSA-5693537","R-HSA-5693537","Resolution of D-Loop Structures","1/36","15/2914",0.170488847537867,0.24755191794198,0.146125360607655,"BRCA1",1
"R-HSA-5693568","R-HSA-5693568","Resolution of D-loop Structures through Holliday Junction Intermediates","1/36","15/2914",0.170488847537867,0.24755191794198,0.146125360607655,"BRCA1",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/36","15/2914",0.170488847537867,0.24755191794198,0.146125360607655,"CTNNB1",1
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","1/36","15/2914",0.170488847537867,0.24755191794198,0.146125360607655,"SMAD3",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","4/36","177/2914",0.17181840211741,0.248712440102053,0.146810395571406,"CDK1/MAPK1/PPP2CA/PPP2R1B",4
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","2/36","62/2914",0.177531067149658,0.256164370217179,0.15120913335679,"MAPK1/PAK1",2
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","1/36","16/2914",0.180789779407007,0.256164370217179,0.15120913335679,"MAPK1",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/36","16/2914",0.180789779407007,0.256164370217179,0.15120913335679,"PAK1",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/36","16/2914",0.180789779407007,0.256164370217179,0.15120913335679,"CSNK2A1",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/36","16/2914",0.180789779407007,0.256164370217179,0.15120913335679,"PAK1",1
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","1/36","16/2914",0.180789779407007,0.256164370217179,0.15120913335679,"MAPK1",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/36","16/2914",0.180789779407007,0.256164370217179,0.15120913335679,"EP300",1
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","2/36","63/2914",0.181993039194882,0.257092576453011,0.151757036487806,"MAPK1/FOS",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/36","64/2914",0.186472908402279,0.262630012134141,0.155025683293186,"EP300/NOTCH1",2
"R-HSA-168927","R-HSA-168927","TICAM1, RIP1-mediated IKK complex recruitment","1/36","17/2914",0.190966303886423,0.267352825440992,0.157813473439526,"TRAF6",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/36","17/2914",0.190966303886423,0.267352825440992,0.157813473439526,"CDK1",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","2/36","66/2914",0.195482038864772,0.272860345915411,0.161064461846601,"EP300/TRAF6",2
"R-HSA-422475","R-HSA-422475","Axon guidance","5/36","254/2914",0.200187049974074,0.278107151077391,0.164161554782525,"MAPK1/CSNK2A1/RPS6KA4/ROCK2/PAK1",5
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/36","18/2914",0.201019881055939,0.278107151077391,0.164161554782525,"PAK1",1
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","1/36","18/2914",0.201019881055939,0.278107151077391,0.164161554782525,"MAPK1",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","2/36","68/2914",0.204550083044745,0.282158791023486,0.166553163593708,"ROCK2/PAK1",2
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/36","19/2914",0.21095195435773,0.28677236693848,0.169276472909483,"EP300",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/36","19/2914",0.21095195435773,0.28677236693848,0.169276472909483,"CTNNB1",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/36","19/2914",0.21095195435773,0.28677236693848,0.169276472909483,"CSNK2A1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/36","19/2914",0.21095195435773,0.28677236693848,0.169276472909483,"EP300",1
"R-HSA-9609507","R-HSA-9609507","Protein localization","1/36","19/2914",0.21095195435773,0.28677236693848,0.169276472909483,"PEX14",1
"R-HSA-69242","R-HSA-69242","S Phase","2/36","71/2914",0.218245148029318,0.295823694045501,0.17461930542917,"RB1/E2F1",2
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","1/36","20/2914",0.220763950780225,0.295823694045501,0.17461930542917,"SP1",1
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/36","20/2914",0.220763950780225,0.295823694045501,0.17461930542917,"TRAF6",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/36","20/2914",0.220763950780225,0.295823694045501,0.17461930542917,"EP300",1
"R-HSA-937041","R-HSA-937041","IKK complex recruitment mediated by RIP1","1/36","20/2914",0.220763950780225,0.295823694045501,0.17461930542917,"TRAF6",1
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/36","21/2914",0.230457281040042,0.303608047212865,0.179214266450417,"CTNNB1",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/36","21/2914",0.230457281040042,0.303608047212865,0.179214266450417,"NOTCH1",1
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","1/36","21/2914",0.230457281040042,0.303608047212865,0.179214266450417,"ROCK2",1
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","1/36","21/2914",0.230457281040042,0.303608047212865,0.179214266450417,"PAK1",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/36","21/2914",0.230457281040042,0.303608047212865,0.179214266450417,"TRAF6",1
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","1/36","21/2914",0.230457281040042,0.303608047212865,0.179214266450417,"TRAF6",1
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","1/36","22/2914",0.240033339761977,0.313581159744756,0.185101212014074,"MAPK1",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/36","22/2914",0.240033339761977,0.313581159744756,0.185101212014074,"PEX14",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/36","22/2914",0.240033339761977,0.313581159744756,0.185101212014074,"EP300",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/36","23/2914",0.249493505657056,0.321462786135053,0.189753591636223,"SMAD4",1
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","1/36","23/2914",0.249493505657056,0.321462786135053,0.189753591636223,"BRCA1",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/36","23/2914",0.249493505657056,0.321462786135053,0.189753591636223,"BRCA1",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/36","23/2914",0.249493505657056,0.321462786135053,0.189753591636223,"STAT1",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/36","23/2914",0.249493505657056,0.321462786135053,0.189753591636223,"E2F1",1
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/36","24/2914",0.258839141698684,0.327211745166261,0.193147096798848,"EP300",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/36","24/2914",0.258839141698684,0.327211745166261,0.193147096798848,"STAT1",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/36","24/2914",0.258839141698684,0.327211745166261,0.193147096798848,"RB1",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/36","24/2914",0.258839141698684,0.327211745166261,0.193147096798848,"PAK1",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/36","24/2914",0.258839141698684,0.327211745166261,0.193147096798848,"BRCA1",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/36","24/2914",0.258839141698684,0.327211745166261,0.193147096798848,"STAT1",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/36","24/2914",0.258839141698684,0.327211745166261,0.193147096798848,"STAT1",1
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","1/36","25/2914",0.268071595296901,0.3361646475782,0.198431831024726,"MAPK1",1
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","1/36","25/2914",0.268071595296901,0.3361646475782,0.198431831024726,"MAPK1",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/36","25/2914",0.268071595296901,0.3361646475782,0.198431831024726,"CSNK2A1",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/36","82/2914",0.269043010311259,0.336483124895947,0.198619822349084,"SMAD3/TRAF6",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/36","26/2914",0.277192198470772,0.34392365365818,0.203011830124793,"MAPK1",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/36","26/2914",0.277192198470772,0.34392365365818,0.203011830124793,"NOTCH1",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/36","26/2914",0.277192198470772,0.34392365365818,0.203011830124793,"CTNNB1",1
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/36","27/2914",0.28620226801892,0.349554332554358,0.206335516691272,"YAP1",1
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/36","27/2914",0.28620226801892,0.349554332554358,0.206335516691272,"CDK1",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/36","27/2914",0.28620226801892,0.349554332554358,0.206335516691272,"NOTCH1",1
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","1/36","27/2914",0.28620226801892,0.349554332554358,0.206335516691272,"TRAF6",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/36","27/2914",0.28620226801892,0.349554332554358,0.206335516691272,"PEX14",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/36","27/2914",0.28620226801892,0.349554332554358,0.206335516691272,"YAP1",1
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/36","28/2914",0.295103105688237,0.357631412319853,0.211103268858987,"PLK1",1
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/36","28/2914",0.295103105688237,0.357631412319853,0.211103268858987,"CDK1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/36","28/2914",0.295103105688237,0.357631412319853,0.211103268858987,"EP300",1
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","1/36","29/2914",0.303895998340775,0.364519752485482,0.215169329825343,"E2F1",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/36","29/2914",0.303895998340775,0.364519752485482,0.215169329825343,"CDK1",1
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","1/36","29/2914",0.303895998340775,0.364519752485482,0.215169329825343,"STAT1",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/36","29/2914",0.303895998340775,0.364519752485482,0.215169329825343,"EP300",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/36","30/2914",0.312582218118845,0.373030687780504,0.220193178961447,"CSNK2A1",1
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","1/36","30/2914",0.312582218118845,0.373030687780504,0.220193178961447,"CSNK2A1",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/36","31/2914",0.321163022608346,0.380367317180087,0.224523856847408,"PAK1",1
"R-HSA-391251","R-HSA-391251","Protein folding","1/36","31/2914",0.321163022608346,0.380367317180087,0.224523856847408,"CSNK2A1",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/36","31/2914",0.321163022608346,0.380367317180087,0.224523856847408,"STAT1",1
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","2/36","94/2914",0.324573811662171,0.383438583550524,0.226336769102879,"STAT1/FOS",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","1/36","32/2914",0.329639655000333,0.384579597500389,0.227010288727645,"MAPK1",1
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","1/36","32/2914",0.329639655000333,0.384579597500389,0.227010288727645,"MAPK1",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/36","32/2914",0.329639655000333,0.384579597500389,0.227010288727645,"STAT1",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/36","32/2914",0.329639655000333,0.384579597500389,0.227010288727645,"EP300",1
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","1/36","32/2914",0.329639655000333,0.384579597500389,0.227010288727645,"MAPK1",1
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/36","33/2914",0.33801334425085,0.390463690772533,0.23048356115627,"TRAF6",1
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","1/36","33/2914",0.33801334425085,0.390463690772533,0.23048356115627,"MAPK1",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/36","33/2914",0.33801334425085,0.390463690772533,0.23048356115627,"BRCA1",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/36","33/2914",0.33801334425085,0.390463690772533,0.23048356115627,"EP300",1
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/36","34/2914",0.346285305239038,0.396116605261241,0.233820372985538,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/36","34/2914",0.346285305239038,0.396116605261241,0.233820372985538,"MAPK1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/36","34/2914",0.346285305239038,0.396116605261241,0.233820372985538,"STAT1",1
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","1/36","34/2914",0.346285305239038,0.396116605261241,0.233820372985538,"MAPK1",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/36","35/2914",0.35445673892355,0.401826446541726,0.23719078765677,"STAT1",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/36","35/2914",0.35445673892355,0.401826446541726,0.23719078765677,"PAK1",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/36","35/2914",0.35445673892355,0.401826446541726,0.23719078765677,"CTNNB1",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","3/36","171/2914",0.354703942149839,0.401826446541726,0.23719078765677,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/36","37/2914",0.370502759540393,0.418712757167336,0.247158467366198,"EP300",1
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/36","38/2914",0.378379680171796,0.426586706732146,0.251806315498944,"TRAF6",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/36","39/2914",0.386160741198853,0.434315078230844,0.256368231567079,"EP300",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/36","109/2914",0.392583930746371,0.438751255982321,0.258986825997869,"EP300/ATF2",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/36","109/2914",0.392583930746371,0.438751255982321,0.258986825997869,"EP300/ATF2",2
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/36","40/2914",0.39384707626558,0.438751255982321,0.258986825997869,"EP300",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/36","40/2914",0.39384707626558,0.438751255982321,0.258986825997869,"CTNNB1",1
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","1/36","41/2914",0.401439805999206,0.444045445786857,0.262111889219938,"STAT1",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/36","41/2914",0.401439805999206,0.444045445786857,0.262111889219938,"STAT1",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/36","41/2914",0.401439805999206,0.444045445786857,0.262111889219938,"MEF2C",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/36","42/2914",0.40894003815515,0.446029948592478,0.263283304858763,"CTNNB1",1
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","1/36","42/2914",0.40894003815515,0.446029948592478,0.263283304858763,"MAPK1",1
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","1/36","42/2914",0.40894003815515,0.446029948592478,0.263283304858763,"MAPK1",1
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","1/36","42/2914",0.40894003815515,0.446029948592478,0.263283304858763,"MAPK1",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/36","42/2914",0.40894003815515,0.446029948592478,0.263283304858763,"STAT1",1
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","1/36","42/2914",0.40894003815515,0.446029948592478,0.263283304858763,"MAPK1",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","3/36","188/2914",0.413181977291486,0.449611014732498,0.265397142575799,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/36","43/2914",0.416348867760448,0.452008377267709,0.266812261747071,"TRAF6",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/36","44/2914",0.423667377255615,0.458891454810354,0.270875216283522,"YAP1",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/36","45/2914",0.430896636634987,0.465646365395873,0.274862516213926,"STAT1",1
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","1/36","46/2914",0.438037703585541,0.47119193344408,0.27813596340656,"NR0B2",1
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","1/36","46/2914",0.438037703585541,0.47119193344408,0.27813596340656,"MAPK1",1
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","1/36","47/2914",0.445091623624216,0.477684145262603,0.281968197068936,"MAPK1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","1/36","48/2914",0.452059430233748,0.484054504063077,0.285728503127796,"TRAF6",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","1/36","49/2914",0.458942144997037,0.488081328806373,0.288105463979522,"STAT1",1
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","1/36","49/2914",0.458942144997037,0.488081328806373,0.288105463979522,"MAPK1",1
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","1/36","49/2914",0.458942144997037,0.488081328806373,0.288105463979522,"MAPK1",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/36","51/2914",0.47245632661334,0.501316780953974,0.29591810883379,"E2F1",1
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","1/36","52/2914",0.479089778322009,0.506065554128428,0.298721222614244,"MAPK1",1
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","1/36","52/2914",0.479089778322009,0.506065554128428,0.298721222614244,"MAPK1",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/36","53/2914",0.485642108154437,0.509543956877921,0.300774460013227,"CSNK2A1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/36","53/2914",0.485642108154437,0.509543956877921,0.300774460013227,"PAK1",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","1/36","53/2914",0.485642108154437,0.509543956877921,0.300774460013227,"TRAF6",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","4/36","296/2914",0.504971033258267,0.528641550442248,0.312047419518149,"PPP2CA/PPP2R1B/PAK1/TRAF6",4
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","3/36","217/2914",0.509128837264023,0.531456369764344,0.313708955780546,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/36","57/2914",0.511059323590019,0.531456369764344,0.313708955780546,"CTNNB1",1
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/36","57/2914",0.511059323590019,0.531456369764344,0.313708955780546,"TRAF6",1
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","1/36","61/2914",0.535253740261037,0.552938335203582,0.326389366308029,"TRAF6",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","1/36","61/2914",0.535253740261037,0.552938335203582,0.326389366308029,"ROCK2",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/36","61/2914",0.535253740261037,0.552938335203582,0.326389366308029,"CSNK2A1",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/36","64/2914",0.552631614993635,0.569635664685747,0.336245493911685,"PAK1",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/36","76/2914",0.616039037170074,0.632215116920711,0.373184997755913,"TRAF6",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/36","76/2914",0.616039037170074,0.632215116920711,0.373184997755913,"CTNNB1",1
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","1/36","77/2914",0.620909577924788,0.63582225337713,0.375314224302963,"MAPK1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","5/36","436/2914",0.644027675439474,0.658058779479549,0.388440038162095,"MAPK1/PPP2CA/PPP2R1B/ROCK2/PAK1",5
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","1/36","88/2914",0.670674140988995,0.683796026356171,0.403632263341203,"MAPK1",1
"R-HSA-109582","R-HSA-109582","Hemostasis","3/36","298/2914",0.728583684913236,0.741227219575505,0.437532844233774,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-112316","R-HSA-112316","Neuronal System","1/36","105/2914",0.735332954277924,0.746474362676075,0.440630136648654,"MAPK1",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","1/36","106/2914",0.738724913568061,0.748298022599181,0.441706609681483,"TRAF6",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","5/36","486/2914",0.741524604389794,0.749515171247443,0.442425070223493,"MAPK1/PPP2CA/PPP2R1B/ROCK2/PAK1",5
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/36","109/2914",0.748649161662302,0.755089154450794,0.445715290361484,"PPP2CA",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","1/36","125/2914",0.795694843388049,0.800817342379818,0.472707801696537,"MAPK1",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/36","126/2914",0.798331984168985,0.801750964829238,0.473258901919178,"CTNNB1",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","1/36","153/2914",0.858250997084615,0.860084866736505,0.507692335207498,"MAPK1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","1/36","165/2914",0.878944736558567,0.878944736558567,0.518824970743807,"MAPK1",1
